[Diffuse interstitial fibrosis of the lung in Hodgkin's disease treated by high doses of endoxan].
D001623:Betamethasone / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D014747:Vinblastine / Q000627:therapeutic use
D008466:Mechlorethamine; D014747:Vinblastine; D003520:Cyclophosphamide; D001623:Betamethasone
Fibrose interstitielle diffuse du poumon au cours d'une maladie de Hodgkin traitée par des doses élevées d'endoxan.